|
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
6 Months Ended |
|
Dec. 28, 2014
|
Dec. 29, 2013
|
| Cash flows from operating activities: |
|
|
| Net income |
$ 23,281 |
$ 66,178 |
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
87,143 |
79,611 |
| Stock-based compensation |
33,196 |
30,250 |
| Excess tax benefit from stock-based payment arrangements |
(1,651) |
(14,853) |
| Loss on disposal or impairment of long-lived assets |
2,182 |
1,417 |
| Amortization of premium/discount on investments |
3,537 |
5,043 |
| Gain on equity method investment |
(679) |
0 |
| Foreign exchange loss on equity method investment |
2,156 |
0 |
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable, net |
5,571 |
(21,029) |
| Inventories |
(47,702) |
(36,632) |
| Prepaid expenses and other assets |
(5,457) |
(6,148) |
| Accounts payable, trade |
(44,784) |
40,501 |
| Accrued salaries and wages and other liabilities |
(28,741) |
23,649 |
| Net cash provided by operating activities |
28,052 |
167,987 |
| Cash flows from investing activities: |
|
|
| Purchases of property and equipment |
(113,375) |
(83,450) |
| Purchases of short-term investments |
(195,892) |
(346,799) |
| Proceeds from maturities of short-term investments |
240,463 |
251,020 |
| Proceeds from sale of property and equipment |
60 |
94 |
| Proceeds from sale of short-term investments |
192,153 |
12,295 |
| Purchases of patent and licensing rights |
(9,604) |
(10,046) |
| Purchase of other long-term investments |
(80,566) |
0 |
| Net cash provided by (used in) investing activities |
33,239 |
(176,886) |
| Cash flows from financing activities: |
|
|
| Proceeds from long-term debt borrowings |
265,000 |
0 |
| Payments on long-term debt borrowings |
(115,000) |
0 |
| Net proceeds from issuance of common stock |
21,089 |
73,079 |
| Excess tax benefit from stock-based payment arrangements |
1,651 |
14,853 |
| Repurchases of common stock |
(320,349) |
(107) |
| Net cash (used in) provided by financing activities |
(147,609) |
87,825 |
| Effects of foreign exchange changes on cash and cash equivalents |
(546) |
393 |
| Net (decrease) increase in cash and cash equivalents |
(86,864) |
79,319 |
| Cash and cash equivalents: |
|
|
| Beginning of period |
286,824 |
190,069 |
| End of period |
$ 199,960 |
$ 269,388 |